GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Shapuaisi Pharmaceutical Co Ltd (SHSE:603168) » Definitions » Shiller PE Ratio

Zhejiang Shapuaisi Pharmaceutical Co (SHSE:603168) Shiller PE Ratio : 49.71 (As of Dec. 12, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Zhejiang Shapuaisi Pharmaceutical Co Shiller PE Ratio?

As of today (2024-12-12), Zhejiang Shapuaisi Pharmaceutical Co's current share price is ¥8.45. Zhejiang Shapuaisi Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 was ¥0.17. Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio for today is 49.71.

The historical rank and industry rank for Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio or its related term are showing as below:

SHSE:603168' s Shiller PE Ratio Range Over the Past 10 Years
Min: 18.86   Med: 31.71   Max: 54.39
Current: 49.71

During the past years, Zhejiang Shapuaisi Pharmaceutical Co's highest Shiller PE Ratio was 54.39. The lowest was 18.86. And the median was 31.71.

SHSE:603168's Shiller PE Ratio is ranked worse than
78.49% of 465 companies
in the Drug Manufacturers industry
Industry Median: 26.8 vs SHSE:603168: 49.71

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Zhejiang Shapuaisi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was ¥-0.010. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is ¥0.17 for the trailing ten years ended in Sep. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Zhejiang Shapuaisi Pharmaceutical Co Shiller PE Ratio Historical Data

The historical data trend for Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhejiang Shapuaisi Pharmaceutical Co Shiller PE Ratio Chart

Zhejiang Shapuaisi Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 58.67

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.68 58.67 47.59 40.44 44.49

Competitive Comparison of Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio falls into.



Zhejiang Shapuaisi Pharmaceutical Co Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=8.45/0.17
=49.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhejiang Shapuaisi Pharmaceutical Co's E10 for the quarter that ended in Sep. 2024 is calculated as:

For example, Zhejiang Shapuaisi Pharmaceutical Co's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.01/115.7848*115.7848
=-0.010

Current CPI (Sep. 2024) = 115.7848.

Zhejiang Shapuaisi Pharmaceutical Co Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201412 0.104 99.000 0.122
201503 0.143 99.900 0.166
201506 0.143 99.500 0.166
201509 0.143 100.500 0.165
201512 0.165 100.600 0.190
201603 0.176 102.200 0.199
201606 0.178 101.400 0.203
201609 0.346 102.400 0.391
201612 0.231 102.600 0.261
201703 0.154 103.200 0.173
201706 0.126 103.100 0.142
201709 0.180 104.100 0.200
201712 -0.010 104.500 -0.011
201803 0.130 105.300 0.143
201806 0.030 104.900 0.033
201809 0.080 106.600 0.087
201812 -0.630 106.500 -0.685
201903 0.060 107.700 0.065
201906 0.020 107.700 0.022
201909 0.040 109.800 0.042
201912 -0.097 111.200 -0.101
202003 0.001 112.300 0.001
202006 -0.046 110.400 -0.048
202009 -0.040 111.700 -0.041
202012 -0.470 111.500 -0.488
202103 0.030 112.662 0.031
202106 0.050 111.769 0.052
202109 0.030 112.215 0.031
202112 0.000 113.108 0.000
202203 0.090 114.335 0.091
202206 0.020 114.558 0.020
202209 0.030 115.339 0.030
202212 0.000 115.116 0.000
202303 0.060 115.116 0.060
202306 0.140 114.558 0.141
202309 0.010 115.339 0.010
202312 -0.140 114.781 -0.141
202403 0.010 115.227 0.010
202406 -0.080 114.781 -0.081
202409 -0.010 115.785 -0.010

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Zhejiang Shapuaisi Pharmaceutical Co  (SHSE:603168) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Zhejiang Shapuaisi Pharmaceutical Co Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Zhejiang Shapuaisi Pharmaceutical Co's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Zhejiang Shapuaisi Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 1588 Xinming Road, Economic Development Zone, Zhejiang Province, Pinghu, CHN, 314200
Zhejiang Shapuaisi Pharmaceutical Co Ltd is a China based pharmaceutical company. It is engaged in drug research and development, production and operation. The product portfolio of the company includes oral solutions, eye drops, tablets, hard capsules, suppositories, granules, raw materials dosage forms such as medicine, rinsing agent and mixture, and others. The company operates pharmaceutical manufacturing companies, pharmaceutical sales company, pharmaceutical retail company and pharmaceutical research institute. The products offered by the company are sold in China and are also exported to the other countries.
Executives
Huang Ming Xiong Directors, senior managers
Wu Jian Guo Director
Xu Hong Sheng senior management
Hu Zheng Guo Director
Ge Sheng Fang Director
Feng Xiao Supervisors
Chen De Kang Director

Zhejiang Shapuaisi Pharmaceutical Co Headlines

No Headlines